Diabetes Drug Onglyza Lawsuits Begin

Noble McIntyre on December 22, 2015


pills Photo Source

If you are living with diabetes, you don’t need us to tell you that it can be tricky business. For most people with diabetes, there’s a constant, daily flow of monitoring blood sugar, food intake and exercise in order to keep the condition under control. Thankfully, there are several drugs on the market today that aim to help you stay healthy and keep your blood sugar in check. The last thing you need, though, is to use a drug that could cause more serious problems down the road. Onglyza, which has been FDA-approved for only six years, has been shown to have side-effects that could include heart failure or pancreatic cancer.

If you are an adult with type 2 diabetes, you could be prescribed Onglyza (generic name: saxagliptin) to lower your blood sugar. It regulates insulin levels after eating because it helps the pancreas secrete more insulin and prevents the liver from producing excess sugar. Like Januvia, Byetta and Janumet, it is an incretin, and there are lawsuits currently in the works for some of those.

The FDA has not issued an Onglyza recall at this time, though the potential exists that there could be one in the future. The FDA did recommend that the drug label include the risks of side-effects.

I’m taking Onglyza. What should I do?

If you have any questions about a drug, device or treatment that you received, the first step is always to consult your doctor. Your doctor’s job is to know and understand how any drug is intended to work for you, how it will interact with other drugs you might be taking, and how it can affect your other medical conditions. Drugs affect each person differently, and every drug has a range of side-effects from mild to severe. However, your doctor is supposed to inform you about the possibility of severe side-effects and what risks are associated with any drug or treatment.

By the same token, a drug manufacturer also has a responsibility to ensure that medications are safe before they hit the market. Sometimes, though, that doesn’t happen the way it should. That’s when you need to contact McIntyre Law. We’re currently pursuing lawsuits for some older incretins, and we’re working on cases regarding Invokana, Actos and Avandia.

Defective Drug Lawsuits

Really, there is no reason why a defective drug lawsuit should ever have to happen. But, they do. And, they are necessary because too many Big Pharma manufacturers don’t properly conduct adequate long-term testing on drugs before they go to market. By the time they start seeing reports that a drug has potentially catastrophic effects, it’s too late for the patients whose lives are forever changed.

If you or a loved one has suffered severe side-effects from Onglyza, another incretin, or any drug, the team at McIntyre Law can help. We have many years of experience handling defective drug lawsuits, and it’s our mission to get you the compensation you need and to which you are entitled in order to restore your quality of life to what it was previously.


Noble McIntyre

Noble McIntyre is the senior partner and owner of McIntyre Law who focuses primarily on drug litigation and catastrophic injury cases. He is currently representing clients injured by the drugs Paxil, Levaquin and testosterone therapy drugs and by clients affected by oil field injuries. His goal has and continues to be to work diligently on behalf of his clients to achieve the highest and best result for his clients’ injuries while maintaining professionalism and abiding by all ethical standards of his profession. Read more about Noble McIntyre.


No responses to “Diabetes Drug Onglyza Lawsuits Begin”


Leave a Reply

Your email address will not be published. Required fields are marked *

*
*
*

© 2017 McIntyre Law, P.C. All Rights Reserved